Cargando…

EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer

BACKGROUND: EZH2 acts as an oncogene through canonical pathway EZH2/H3K27Me3 and uncanonical pathway pAkt1/pS21EZH2 in many solid tumors including ovarian cancer. However, the clinical value of EZH2/H3K27Me3 and pAkt1/pS21EZH2 remain unclear. In the current study, we aim to investigate the correlati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Si, Yang, Qiang, Cai, E, Huang, Bangxing, Ying, Feiquan, Wen, Yiping, Cai, Jing, Yang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2020
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227641/ https://www.ncbi.nlm.nih.gov/pubmed/32435534 http://dx.doi.org/10.7717/peerj.9052

Ejemplares similares

EZH2-mediated H3K27me3 inhibits ACE2 expression
por: Li, Yuanyuan, et al.
Publicado: (2020)

Androgens regulate ovarian gene expression by balancing Ezh2-Jmjd3 mediated H3K27me3 dynamics
por: Roy, Sambit, et al.
Publicado: (2021)

EZH2-Mediated H3K27me3 Targets Transcriptional Circuits of Neuronal Differentiation
por: Buontempo, Serena, et al.
Publicado: (2022)

Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent
por: Yang, Jun, et al.
Publicado: (2022)

The EZH2-H3K27me3 axis modulates aberrant transcription and apoptosis in cyclophosphamide-induced ovarian granulosa cell injury
por: Chen, Yingyan, et al.
Publicado: (2023)

FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3
por: Xiong, Xifeng, et al.
Publicado: (2022)

EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer
por: Chinaranagari, Swathi, et al.
Publicado: (2014)

EZH2-mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma
por: Hou, Chen, et al.
Publicado: (2022)

EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
por: Verma, Ayushi, et al.
Publicado: (2022)

Computational inference of H3K4me3 and H3K27ac domain length
por: Zubek, Julian, et al.
Publicado: (2016)

EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
por: Yoo, Kyung Hyun, et al.
Publicado: (2011)

The EZH2–PRC2–H3K27me3 axis governs the endometrial cell cycle and differentiation for blastocyst invasion
por: Fukui, Yamato, et al.
Publicado: (2023)

Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming
por: Rao, Radhika Arasala, et al.
Publicado: (2015)

Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3
por: Yu, Yongxin, et al.
Publicado: (2018)

Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3
por: Yu, Yongxin, et al.
Publicado: (2017)

H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
por: Hoffmann, Friederike, et al.
Publicado: (2020)

Role of EZH2-mediated H3K27me3 in placental ADAM12-S expression: implications for fetoplacental growth
por: Zhu, Ya-nan, et al.
Publicado: (2022)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
por: Yi, Xiaoqing, et al.
Publicado: (2017)

EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
por: Au, Sandy Leung-Kuen, et al.
Publicado: (2013)

EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer
por: Liu, Ting, et al.
Publicado: (2021)

EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells
por: Wen, Yiping, et al.
Publicado: (2021)

Correction: EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
por: Au, Sandy Leung-Kuen, et al.
Publicado: (2014)

Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma
por: Cho, Yong Jin, et al.
Publicado: (2018)

Azithromycin attenuates wheezing after pulmonary inflammation through inhibiting histone H3K27me3 hypermethylation mediated by EZH2
por: Wu, Shuqi, et al.
Publicado: (2023)

EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia
por: Li, Jiali, et al.
Publicado: (2013)

Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts
por: Zhu, Wen-Si, et al.
Publicado: (2016)

ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer
por: Hua, Tian, et al.
Publicado: (2021)

Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer
por: Benard, Anne, et al.
Publicado: (2014)

LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1
por: Qin, Jianzhang, et al.
Publicado: (2022)

Astronauts Plasma-Derived Exosomes Induced Aberrant EZH2-Mediated H3K27me3 Epigenetic Regulation of the Vitamin D Receptor
por: Bisserier, Malik, et al.
Publicado: (2022)

Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013)

Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis
por: Ma, Shao-Jun, et al.
Publicado: (2018)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

Transcriptome and H3K27 tri-methylation profiling of Ezh2-deficient lung epithelium
por: Holik, Aliaksei Z., et al.
Publicado: (2015)

Intermittent High Glucose Elevates Nuclear Localization of EZH2 to Cause H3K27me3-Dependent Repression of KLF2 Leading to Endothelial Inflammation
por: Thakar, Sumukh, et al.
Publicado: (2021)

CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity
por: Huo, Xiao, et al.
Publicado: (2020)

EZH2 in Myeloid Malignancies
por: Rinke, Jenny, et al.
Publicado: (2020)

Tazemetostat: EZH2 Inhibitor
por: Straining, Rachael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9a8rr4mqrlfhtr43v0hg0psak9